Tech Company Financing Transactions
Signadori Bio Funding Round
Invivo Capital, Sofinnova Partners and Taiho Ventures participated in a $13 million Seed capital raise for Signadori Bio. The round closed on 5/6/2026.
Transaction Overview
Company Name
Announced On
5/6/2026
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Paris, Undisclosed
France
Paris, Undisclosed
France
Phone
Undisclosed
Email Address
Not Recorded
Overview
Signadori Bio is a preclinical stage biopharmaceutical company developing an innovative cell therapy approach to treat cancer. The proprietary platform developed by Signadori comes from Institut Gustave Roussy a world leading oncology center. Signadori is based in Paris, France.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthieu Coutet
Browse more venture capital transactions:
Prev: 5/6/2026: Xbow venture capital transaction
Next: 5/6/2026: InstaSwitch venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs